We are live on
!
Find out more
PC
Pavadi Capital Portfolio holdings
AUM
$81.2M
1-Year Est. Return
5.26%
This Fund
S&P 500
This Quarter
Est. Return
-9.13%
1 Year Est. Return
+5.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76.8M
AUM Growth
-$8.94M
(-10%)
Cap. Flow
-$1.66M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
70.04%
Holding
19
New
4
Increased
2
Reduced
10
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
InMode
INMD
|
+$6.09M |
| 2 |
PINC
Premier
PINC
|
+$6M |
| 3 |
GE HealthCare
GEHC
|
+$5.78M |
| 4 |
Cardinal Health
CAH
|
+$5.27M |
| 5 |
Lantheus
LNTH
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMN Healthcare
AMN
|
+$7.03M |
| 2 |
Baxter International
BAX
|
+$6.41M |
| 3 |
Avantor
AVTR
|
+$5.87M |
| 4 |
Humana
HUM
|
+$2.59M |
| 5 |
Tenet Healthcare
THC
|
+$793K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Molina Healthcare
MOH
$10.2B
| $7M | 9.11% |
21,340
-383
| -2% | -$121K |
|
|
2
Tenet Healthcare
THC
$20.5B
| $6.11M | 7.95% |
92,667
-10,613
| -10% | -$793K |
|
|
3
Lantheus
LNTH
$6.49B
| $5.95M | 7.75% |
85,594
+18,210
| +27% | +$1.33M |
|
|
PDCO
4
DELISTED
Patterson Companies, Inc.
PDCO
| $5.46M | 7.11% |
184,127
-10,257
| -5% | -$325K |
|
|
5
GE HealthCare
GEHC
$30.7B
| $5.41M | 7.04% |
+79,488
| New | +$5.78M |
|
|
PINC
6
DELISTED
Premier
PINC
| $5.17M | 6.74% |
+240,681
| New | +$6M |
|
|
7
Cardinal Health
CAH
$53.9B
| $5.06M | 6.6% |
+58,331
| New | +$5.27M |
|
|
8
InMode
INMD
$870M
| $4.73M | 6.16% |
+155,217
| New | +$6.09M |
|
9
QuidelOrtho
QDEL
$1.14B
| $4.45M | 5.8% |
60,963
-7,901
| -11% | -$631K |
|
10
Centene
CNC
$30.7B
| $4.44M | 5.78% |
64,391
-7,410
| -10% | -$493K |
|
11
CVS Health
CVS
$133B
| $3.91M | 5.09% |
56,018
-6,900
| -11% | -$489K |
|
12
UnitedHealth
UNH
$376B
| $3.89M | 5.06% |
7,711
-824
| -10% | -$406K |
|
13
HCA Healthcare
HCA
$87.2B
| $3.86M | 5.03% |
15,711
+333
| +2% | +$91.1K |
|
14
Integra LifeSciences
IART
$1.29B
| $3.82M | 4.97% |
99,999
-11,956
| -11% | -$503K |
|
|
15
Humana
HUM
$43.7B
| $3.81M | 4.96% |
7,822
-5,508
| -41% | -$2.59M |
|
16
Envista
NVST
$4.44B
| $3.72M | 4.84% |
133,299
-17,946
| -12% | -$581K |
|
|
17
AMN Healthcare
AMN
$1.3B
| – | – |
-64,395
| Closed | -$7.03M |
|
|
18
Avantor
AVTR
$9.32B
| – | – |
-285,624
| Closed | -$5.87M |
|
|
19
Baxter International
BAX
$13.5B
| – | – |
-140,613
| Closed | -$6.41M |
|
Similar funds
BAM
TCM
JAM
HH
CPI
SLM
AFG
TIMH
Pavadi Capital's Q3 2023 Portfolio in Review
As of Q3 2023, Pavadi Capital held 19 positions worth $76.8M, down 10% from $85.7M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Pavadi Capital's Q3 2023 filing shows 4 new, 2 increased, 10 reduced and 3 closed positions. Its largest new stake was InMode: 155,217 shares worth $4.73M. The largest sale was AMN Healthcare, an estimated $7.03M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Pavadi Capital's largest Q3 2023 buy was InMode: 155,217 shares worth $4.73M.
- Pavadi Capital added most to Lantheus in Q3 2023, an estimated $1.33M increase.
- Pavadi Capital's biggest Q3 2023 reduction was Humana, cutting an estimated $2.59M.
- Pavadi Capital fully exited AMN Healthcare in Q3 2023, selling an estimated $7.03M.
- Pavadi Capital's ten largest holdings make up 70% of its $76.8M portfolio in Q3 2023.
- Pavadi Capital opened 4 new positions and closed 3 in Q3 2023.
- Pavadi Capital's portfolio value fell 10% quarter-over-quarter to $76.8M.
Based on Pavadi Capital's 13F filing for Q3 2023, filed 14 Nov 2023.